Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
APGE Apogee Therapeutics
- 31.080
- -1.980-5.99%
Close Feb 26 16:00 ET
- 31.050
- -0.030-0.10%
Pre 05:48 ET
1.82BMarket Cap-12.06P/E (TTM)
34.470High30.640Low608.72KVolume33.390Open33.060Pre Close19.38MTurnover1.54%Turnover RatioLossP/E (Static)58.51MShares72.29052wk High2.48P/B1.23BFloat Cap30.64052wk Low--Dividend TTM39.49MShs Float72.290Historical High--Div YieldTTM11.59%Amplitude14.190Historical Low31.843Avg Price1Lot Size
About Apogee Therapeutics Company
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.
Company Profile
SymbolAPGE
Company NameApogee Therapeutics
Listing DateJul 14, 2023
Issue Price17.00
Founded2022
CEODr. Michael Henderson, M.D.
MarketNASDAQ
Employees91
Fiscal Year Ends12-31
Address221 Crescent Street,Building 17, Suite 102b
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-650-394-5230
Company Executives
- Name
- Position
- Salary
- Dr. Michael Henderson, M.D.
- Chief Executive Officer and Director
- 1.17M
- Jane Pritchett Henderson
- Chief Financial Officer and Chief Accounting Officer
- 1.72M
- Dr. Carl Dambkowski, M.D.
- Chief Medical Officer
- 870.83K
- Mark C. McKenna
- Chairman of the Board
- 972.87K
- Dr. Lisa L. Bollinger, M.D.
- Director
- --
- Tomas Kiselak
- Independent Director
- 662.82K
- Nimish Shah
- Independent Director
- 664.82K
- Dr. Andrew Gottesdiener, M.D.
- Independent Director
- 666.57K
- Jennifer A. Fox
- Independent Director
- 414.57K
- William B.J. Jones, Jr
- Independent Director
- 411.66K
- Peter Harwin
- Independent Director
- 668.57K